Your browser doesn't support javascript.
loading
Genetics of Diffuse Idiopathic Skeletal Hyperostosis and Ossification of the Spinal Ligaments.
Kato, Hajime; Braddock, Demetrios T; Ito, Nobuaki.
Afiliación
  • Kato H; Division of Nephrology and Endocrinology, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan.
  • Braddock DT; Osteoporosis Center, The University of Tokyo Hospital, Tokyo, Japan.
  • Ito N; Department of Pathology, Yale University, New Haven, CT, USA.
Curr Osteoporos Rep ; 21(5): 552-566, 2023 10.
Article en En | MEDLINE | ID: mdl-37530996
ABSTRACT
PURPOSE OF REVIEW The study aims to provide updated information on the genetic factors associated with the diagnoses 'Diffuse Idiopathic Skeletal Hyperostosis' (DISH), 'Ossification of the Posterior Longitudinal Ligament' (OPLL), and in patients with spinal ligament ossification. RECENT

FINDINGS:

Recent studies have advanced our knowledge of genetic factors associated with DISH, OPLL, and other spinal ossification (ossification of the anterior longitudinal ligament [OALL] and the yellow ligament [OYL]). Several case studies of individuals afflicted with monogenic disorders, such as X-linked hypophosphatemia (XLH), demonstrate the strong association of fibroblast growth factor 23-related hypophosphatemia with OPLL, suggesting that pathogenic variants in PHEX, ENPP1, and DMP1 are associated with FGF23-phosphate wasting phenotype and strong genetic factors placing patients at risk for OPLL. Moreover, emerging evidence demonstrates that heterozygous and compound heterozygous ENPP1 pathogenic variants inducing 'Autosomal Recessive Hypophosphatemic Rickets Type 2' (ARHR2) also place patients at risk for DISH and OPLL, possibly due to the loss of inhibitory plasma pyrophosphate (PPi) which suppresses ectopic calcification and enthesis mineralization. Our findings emphasize the importance of genetic and plasma biomarker screening in the clinical evaluation of DISH and OPLL patients, with plasma PPi constituting an important new biomarker for the identification of DISH and OPLL patients whose disease course may be responsive to ENPP1 enzyme therapy, now in clinical trials for rare calcification disorders.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Osificación del Ligamento Longitudinal Posterior / Hiperostosis Esquelética Difusa Idiopática Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Curr Osteoporos Rep Asunto de la revista: ORTOPEDIA Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Osificación del Ligamento Longitudinal Posterior / Hiperostosis Esquelética Difusa Idiopática Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Curr Osteoporos Rep Asunto de la revista: ORTOPEDIA Año: 2023 Tipo del documento: Article País de afiliación: Japón